Blackmail at the USPTO? Director Issues Decision Regarding Inter Partes Review Related to High-Stakes Patent Litigation READ MORE
Mylan Failed to “Immediately Envisage” the Compounds in Merck’s Patent Covering Januvia READ MORE
Can Different Theories of Patent Invalidity Be Deemed Different Issues for Collateral Estoppel Purposes? READ MORE
Senate Bill and FTC 6(b) Study Turn the Heat on Pharmacy Benefit Managers Amid Drug Pricing Concerns READ MORE